Discover the full management transaction log of KERYX BIOPHARMACEUTICALS INC, a listed equity based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). The latest transaction was reported on 10 February 2016 (Cession). Among the most active insiders: Adams Brian. All data is accessible without an account.
10
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
6 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.